The impact of CBP expression in estrogen receptor-positive breast cancer.

Wafaa S RamadanIman M TalaatMahmood Y HachimAnnette LischkaTimo GemollRaafat El-Awady

Published in: Clinical epigenetics (2021)

We conclude that the persistent amplification and overexpression of CBP in ERα- and PR-positive BC highlights the significance of CBP as a new diagnostic marker and therapeutic target in hormone-positive BC.

Keyphrases

estrogen receptor
positive breast cancer
poor prognosis
binding protein
breast cancer cells